Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
08 Abril 2024 - 7:00AM
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology
company working to develop the world’s most potent vaccines, today
announced that management will be participating in the following
investor and scientific conferences. Select events (marked by *)
will be webcasted live and webcast details will be available on the
‘Events’ page of Gritstone bio’s website:
https://ir.gritstonebio.com/investors/events. Archived replays will
be accessible for 30 days following each event.
23rd Annual Needham
Virtual Healthcare Conference (Presentation*)Date and
Time: Tuesday, April 9, 2024 at 11:00am
ETLocation: Virtual
Canaccord Genuity Horizons in Oncology Virtual
Conference (Panel)Panel Title: Cancer Vaccines – Building
on Recent LearningsDate and Time: Monday, April 15,
2024 at 11:00am ETLocation: Virtual
Cambridge Healthtech Institute’s Immuno-Oncology Summit
Europe (Presentation)Presentation Title: Clinical Trial
Results with a Personalised Neoantigen Vaccine in a Cold Tumour—Can
We Bring the Heat?Date and Time: Wednesday, April 24,
2024 at 9:05am BSTLocation: London, UK
7th International
Neoantigen Summit (Presentation)Panel Title: Clinical
Trial Data with a Personalised Neoantigen Cancer Vaccine in
MetastaticColorectal CancerPanel Date and Time: Tuesday, April
30, 2024 at 12:30pm CESTLocation: Amsterdam,
Netherlands
PEGS BOSTON (Panel)Panel Title: Personalized
Cancer Vaccines - Where are They Going Now?Date and
Time: Monday, May 13, 2024 at 9:00am
ETLocation: Boston, MA
Citizens JMP Life Sciences Conference (Fireside
Chat*)Date and Time: Tuesday, May 14, 2024 at 10:30am
ETLocation: New York, NY
About Gritstone bioGritstone bio, Inc. (Nasdaq:
GRTS) is a clinical-stage biotechnology company that aims to
develop the world’s most potent vaccines. We leverage our
innovative vectors and payloads to train multiple arms of the
immune system to attack critical disease targets. Independently and
with our collaborators, we are advancing a portfolio of product
candidates to treat and prevent viral diseases and solid tumors in
pursuit of improving patient outcomes and eliminating disease.
www.gritstonebio.com
Gritstone ContactsInvestors:George E.
MacDougallGritstone bio, Inc.ir@gritstone.com
Media:Dan Budwick1AB(973) 271-6085dan@1abmedia.com
Gritstone bio (NASDAQ:GRTS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Gritstone bio (NASDAQ:GRTS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024